NAS:ALBO (USA) Also Trade In: Germany
Warning! GuruFocus has detected 1 Severe warning sign with ALBO. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Albireo Pharma Inc () from 2007 to Apr 17 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Albireo Pharma stock (ALBO) PE ratio as of Apr 17 2021 is 0. More Details
Albireo Pharma PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Albireo Pharma PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
10 Post Office Square, Suite 502, South Boston, MA, USA, 02109
Albireo Pharma Inc is a biopharmaceutical company. It engages in the research and development of drug reformulation technology. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal.